Laween Uthman

机构：Radboud University Nijmegen, University Medical Center, Radboud University Medical Center · ORCID：0000-0003-2391-8407

发表论文 19 篇 · 总被引 1401 次 · h-index 10

代表论文

• Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation (2017 · Diabetologia · 被引 608)
• Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells (2019 · Cellular Physiology and Biochemistry · 被引 210)
• Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients (2018 · Frontiers in Physiology · 被引 190)
• Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells (2021 · Biomedicine & Pharmacotherapy · 被引 112)
• Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts (2019 · Cardiovascular Research · 被引 97)
• Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells (2020 · Cardiovascular Drugs and Therapy · 被引 70)